Prostate cancer screen warning

Any UK screening programme for prostate cancer will need to account for changes in risks and benefits in different age groups, scientists at Cancer Research UK believe.

Dr Nora Pashyan and colleagues gave over 40,000 men PSA testing as part of a study to identify advanced stage prostate cancers. PSA testing led to an overdiagnosis of about one in 10 of those in the 50-59 age group but this increased to three in 10 in the 60-69 age group.

Dr Pashyan said: 'Any screening strategy should take into account the potential benefits and harms of screening.

'A valuable target for future research would be to estimate the benefit of screening at different ages.'

The DoH is currently reviewing the case for PSA screening for prostate cancer.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in